The following table presents the details of the Company's share-based compensation expense (in millions):


	Three Months Ended June 30,
		2026		2025
Cost of sales(1)		$	8.7	$	7.7
Research and development		41.1		29.1
Selling, general and administrative		25.2		16.1

Pre-tax effect of share-based compensation		75.0		52.9
Income tax benefit		15.5		10.9
Net income effect of share-based compensation		$	59.5	$	42.0

(1) During the three months ended June 30, 2026, $6.5 million of share-based compensation expense was capitalized to inventory and $8.7 million of previously capitalized share-based compensation expense in inventory was sold. During the three months ended June 30, 2025, $3.6 million of share-based compensation expense was capitalized to inventory and $7.7 million of previously capitalized share-based compensation expense in inventory was sold.